JYP-0322

Primary Research Objectives: 1) To quantitatively analyze the total radioactivity in urine and feces of healthy male participants after a single oral administration of [14C]JYP0322, obtaining data on the human body's radioactive excretion rate and main excretion pathways; 2) To obtain the radiometabolite profiles in plasma, urine, and feces of healthy male participants after a single oral administration of [14C]JYP0322, identifying the main metabolites and determining the main metabolic and elimination pathways of JYP0322 in the human body; 3) To quantitatively analyze the total radioactivity in plasma of healthy male participants after a single oral administration of [14C]JYP0322, obtaining the pharmacokinetic parameters of total plasma radioactivity; Secondary Research Objectives: 1) To quantitatively analyze the concentration of JYP0322 and its metabolites (if applicable) in plasma using a validated LC-MS/MS method, obtaining the pharmacokinetic parameters of JYP0322 and its metabolites (if applicable) in plasma; 2) 3) Evaluate the safety of a single dose of [14C]JYP0322 in healthy male participants.